Immunomodulation of gut-associated lymphoid tissue: current perspectives (Q37642859)

21 August 2017

1 reference

title

Immunomodulation of gut-associated lymphoid tissue: current perspectives (English)

1 reference

21 August 2017

1 reference

Paolo Bergamo

3

0 references

Francesco Maurano

object named as

Francesco Maurano

4

0 references

Mauro Rossi

object named as

Mauro Rossi

5

0 references

author name string

Diomira Luongo

1

1 reference

PubMed ID

19954358

21 August 2017

Rossana D'Arienzo

2

1 reference

21 August 2017

1 January 2009

1 reference

International Reviews of Immunology

21 August 2017

1 reference

21 August 2017

28

1 reference

21 August 2017

6

1 reference

21 August 2017

446-464

1 reference

Mucosal immunity and tolerance: relevance to vaccine development

21 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Intestinal IgA synthesis: regulation of front-line body defences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Gut lymphocyte migration: we are halfway 'home'.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Structural basis for the activation of cholera toxin by human ARF6-GTP

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

In vivo activity of cationic immune stimulating complexes (PLUSCOMs).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Contrasting activity of cytosin–guanosin dinucleotide oligonucleotides in mice with experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Immunomodulation using bacterial enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

The Toll receptor family and microbial recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Dendritic cells of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Dendritic cells at the host-pathogen interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Intestinal barrier function: molecular regulation and disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Proinflammatory effects of local abdominal irradiation on rat gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in Type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Coeliac disease: dissecting a complex inflammatory disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Latest developments in the pathogenesis and treatment of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Adaptive and innate immune responses in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

A porous defense: the leaky epithelial barrier in intestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Intestinal digestive resistance of immunodominant gliadin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Structural basis for gluten intolerance in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Oral proteases: a new approach to managing coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Prolyl endopeptidase catalysis. A physical rather than a chemical step is rate-limiting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830180903236486

10.3109/08830180903236486

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19954358